Company: BNBX
Filing Date: 2025-05-22
Form Type: 8-K
Source: 0001104659-25-051992
Chunk: 0

Company: BNB PLUS CORP.
Filing Date: 2025-05-22
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07      Submission of Matters to a Vote of Security Holders.  

On May 22, 2025, Applied
DNA Sciences, Inc. (the “ Company”) held its 2025 annual meeting of stockholders (the “ Annual Meeting”). The following
proposals were voted on at the Annual Meeting with the stockholders having voted as set forth below:

I. To elect six directors
to serve until the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified.

 ──────────────────────────────────────────────────────────────────────
  James A. Hayward               571,758      117,757      1,672,764  
  Robert B. Catell               573,429      116,086      1,672,764  
  Joseph D. Ceccoli              573,283      116,232      1,672,764  
  Yacov A. Shamash               572,491      117,024      1,672,764  
  Sanford R. Simon               572,906      116,609      1,672,764  
  Elizabeth Schmalz Shaheen      571,561      117,954      1,672,764  

II. To ratify the appointment
of CBIZ CPAs P. C. as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2025.

  FOR                     AGAINST                   ABSTAIN              
 ─────────────────────────────────────────────────────────────────────────
           2,239,750                   108,014                   14,515  

III. To grant the board of directors of the Company
(the “ Board”) discretionary authority for 12 months to amend the Company’s certificate of incorporation, as amended,
to authorize a reverse stock split of common stock, at a ratio in the range from one-for-five to one-for-fifty, with such specific ratio
to be determined by the Board following the Annual Meeting.

  FOR                     AGAINST                   ABSTAIN             
 ────────────────────────────────────────────────────────────────────────
           1,705,824                   653,968                   2,487  

IV. To approve, in accordance with Nasdaq Listing
Rule 5635(d), the exercisability of certain common stock purchase warrants, and the issuance of the common stock underlying such warrants,
which warrants were issued in connection with